Used in pharmaceutical research as a key intermediate in the synthesis of nicotinic acetylcholine receptor (nAChR) modulators. It shows potential in the development of treatments for neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia due to its ability to selectively target receptor subtypes involved in cognitive and memory functions. Also investigated for use in antidepressant and anxiolytic agents owing to its influence on central nervous system signaling pathways. Its structural properties make it suitable for optimizing drug candidates with improved blood-brain barrier penetration and metabolic stability.